Table 1. Clinicopathological features.
N | % | |
---|---|---|
Age (years) | ||
⩽40 | 157 | 12.7 |
41–50 | 273 | 22.1 |
51–65 | 531 | 43 |
66–75 | 210 | 17 |
>75 | 64 | 5.2 |
Clinical tumour size (cT) | ||
T0 | 213 | 17.3 |
T1 | 675 | 54.7 |
T2 | 310 | 25.1 |
T3 | 36 | 2.9 |
Unknown | 3 | |
Pathological tumour size (mm) | ||
0–5 | 76 | 6.2 |
5.1–10 | 190 | 15.4 |
10.1–20 | 549 | 44.6 |
20.1–30 | 243 | 19.8 |
>30 | 172 | 14 |
Pathological subtype | ||
Ductal | 1051 | 85 |
Lobular | 58 | 4.7 |
Mixed | 5 | 0.4 |
Medullary | 42 | 3.4 |
Others | 81 | 6.5 |
Tumour grade | ||
1 | 95 | 7.7 |
2 | 291 | 23.5 |
3 | 822 | 66.5 |
Unknown | 29 | 2.3 |
LVI | ||
No | 848 | 68.6 |
Yes | 277 | 22.4 |
Unknown | 112 | 9 |
Pathological ALN status | ||
pN0 | 951 | 77.2 |
pN0(i+) | 35 | 2.8 |
pN1mic | 55 | 4.5 |
pN1 | 191 | 15.5 |
Metastatic evolution | ||
No | 1089 | 88 |
Yes | 148 | 12 |
Breast surgical resection | ||
Conservative | 613 | 81 |
Mastectomy | 144 | 19 |
SLN biopsy | ||
No | 348 | 28.1 |
Yes | 889 | 71.9 |
ALN dissection | ||
No | 648 | 52.4 |
Yes | 588 | 47.6 |
Adjuvant chemotherapy | ||
No | 288 | 23.3 |
Yes | 949 | 76.7 |
Abbreviations: ALN=axillary lymph node; LVI=lymphovascular invasion; N=number of patients; pN=pathological lymph onde involvement; SLN=sentinel lymph node.